A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT01038388 · COMPLETED
Trial details
- NCT number
- NCT01038388
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-15
- Primary completion
- 2021-08-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.